A dual P2X3 and P2X2/3 receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

AF-353 (hydrochloride)

Item No. 23034

Technical Information
Formal Name
5-[5-iodo-4-methoxy-2-(1-methylethyl)phenoxy]-2,4-pyrimidinediamine, monohydrochloride
CAS Number
927887-18-1
Molecular Formula
C14H17IN4O2 • HCl
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMSO: 20 mg/ml
λmax
231 nm
SMILES
COC1=CC(C(C)C)=C(OC2=C(N)N=C(N)N=C2)C=C1I.Cl
InChi Code
InChI=1S/C14H17IN4O2.ClH/c1-7(2)8-4-11(20-3)9(15)5-10(8)21-12-6-18-14(17)19-13(12)16;/h4-7H,1-3H3,(H4,16,17,18,19);1H
InChi Key
QRBBKDZPXABQPE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    AF-353 is a noncompetitive dual antagonist of the purinoreceptors P2X3 and P2X2/3 (IC50s = 10 and 79.4 nM, respectively).1,2 It is selective for P2X3 and P2X2/3 over P2X1, P2X2, P2X4, P2X5, and P2X7 (IC50 = >10 µM for all).2 It inhibits calcium flux in CHO-K1 cells expressing the rat P2X3 receptor and in 1321N1 cells expressing the human P2X3 and P2X2/3 receptors (IC50s = 8.91, 8.71, and 38.9 nM, respectively). AF-353 decreases the electrical signals in the detrusor, but not striated, muscle of the bladder in female rats.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Carter, D.S., Alam, M., Cai, H., et alIdentification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X3/P2X2/3 antagonist for the treatment of pain. Bioorg. Med. Chem. Lett. 19(6), 1628-1631 (2009).

    2. Gever, J.R., Soto, R., Henningsen, R.A., et alAF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Br. J. Pharmacol. 160(6), 1387-1398 (2010).

    3. Salazar, B.H., Hoffman, K.A., Zhang, C., et alElectrical activity of the bladder Is attenuated by intravesical inhibition of P2X2/3 receptors during micturition in female rats. Int. Neurourol. J. 21(4), 259-269 (2017).